Jae Won Chang

USPTO Granted Patents = 16 (Patent Applications = 3)

CIPO Patents = 1

EPO Patents = 4 (Patent Applications = 5)

Average Co-Inventor Count = 6.2

ph-index = 8

Forward Citations = 226(Granted Patents)

Location History:

Boston, MA (US) (2013 - 2014)
La Jolla, CA (US) (2016)
San Diego, CA (US) (2014 - 2024)

Company Filing History:

12 out of 1,186

The Scripps Research Institute

patents

8 out of 1,206

Dana-farber-cancer Institute Inc.

patents

4 out of 18

Abide Therapeutics, Inc.

patents

4. 2 out of 303

Whitehead Institute for Biomedical Research

Lundbeck La Jolla Research Center, Inc.

patents

where one patent can have more than one assignee

Years Active: 2013-2024

Loading Chart...

16 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12018004 - Carbamate compounds and methods of making and using same (2024-06-25),

2. 11932646 - Small molecule myristate inhibitors of Bcr-abl and methods of use (2024-03-19),

3. 11530189 - Carbamate compounds and methods of making and using same (2022-12-20),

4. 11254682 - Small molecule myristate inhibitors of Bcr-abl and methods of use (2022-02-22),

5. 11021453 - Carbamate compounds and methods of making and using same (2021-06-01),

6. 10787455 - Small molecule myristate inhibitors of BCR-ABL and methods of use (2020-09-29),

7. 9957242 - Carbamate compounds and methods of making and using same (2018-05-01),

8. 9567302 - Carbamate compounds and of making and using same (2017-02-14),

9. 9505784 - Fused 2-aminothiazole compounds (2016-11-29),

10. 9487495 - Carbamate compounds and of making and using same (2016-11-08),

11. 9249128 - Anti-cancer serine hydrolase inhibitory carbamates (2016-02-02),

12. 9133148 - Carbamate compounds and of making and using same (2015-09-15),

13. 8921336 - Small molecule myristate inhibitors of BCR-ABL and methods of use (2014-12-30),

14. 8889706 - Soluble mTOR complexes and modulators thereof (2014-11-18),

15. 8765747 - Fused 2-aminothiazole compounds (2014-07-01),

Title: Unveiling the Innovations of Inventor Jae Won Chang

Introduction:

In the realm of inventions and breakthroughs, inventor Jae Won Chang emerges as a prominent figure, hailing from the vibrant city of San Diego, California. With a remarkable portfolio boasting 15 patents, Chang has been at the forefront of pioneering advancements in the field of medicinal chemistry and pharmaceuticals.

Latest Patents:

Chang's latest patents showcase his expertise and ingenuity. One of his recent creations includes "Small molecule myristate inhibitors of Bcr-abl," offering a novel approach for combating various types of cancers. Additionally, his patent on "Carbamate compounds as modulators of MAGL and/or ABHD6" presents innovative methods for treating patients with post-traumatic stress disorder.

Career Highlights:

Having made significant contributions to the scientific community, Jae Won Chang has been associated with esteemed institutions such as The Scripps Research Institute and Dana-Farber Cancer Institute. His dedication to research and development has not only led to groundbreaking inventions but has also paved the way for transformative discoveries in the pharmaceutical industry.

Collaborations:

Throughout his career, Chang has collaborated with industry experts and visionaries, including notable peers such as Nathanael Schiander Gray and Jianming Zhang. These collaborations have not only enriched his projects but have also fostered a culture of innovation and knowledge-sharing within the scientific community.

Conclusion:

Inventor Jae Won Chang's unwavering commitment to innovation and scientific advancement has solidified his position as a trailblazer in the field of medicinal chemistry. His relentless pursuit of excellence and groundbreaking inventions continue to shape the landscape of modern medicine, offering hope and transformative solutions to individuals in need.

This text is generated by artificial intelligence and may not be accurate.